544445 — Asston Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Asston Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	13.7	1.24	0.064	1.99	12.9
Net Total Accounts Receivable
Net Total Receivables	62.1	90.7	169	261	385
Total Inventory
Total Other Current Assets
Total Current Assets	80.5	107	183	270	406
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.78	11.3	10.9	9.56	107
Long Term Notes Receivable
Other Long Term Assets
Total Assets	89.3	137	203	281	516
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	54.5	97.9	121	150	89.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	80	117	139	174	128
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.31	19.9	63.9	107	389
Total Liabilities & Shareholders' Equity	89.3	137	203	281	516
Total Common Shares Outstanding